Skip to main content
logo
CVS Health Corporation (CVS)
NYSE: CVS · Real-Time Price · USD
83.85
+2.52 (3.10%)
At close: Nov 6, 2026, 4:00 PM EST
84.18
+0.33 (0.39%)
After-hours: Nov 6, 2026, 7:58 PM EST

CVS Health Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Revenue
107,752105,45599,852105,099102,23998,42894,06896,95594,87890,84087,98393,54589,48788,64784,94483,52380,95880,49076,65876,237
Revenue Growth (YoY)
5.39%7.14%6.15%8.40%7.76%8.35%6.92%3.65%6.02%2.47%3.58%12.00%10.54%10.13%10.81%9.56%10.08%11.29%11.42%-
Cost of Revenue
93,50190,34784,80292,12689,06585,32280,19284,81182,87077,85175,87679,93776,18775,31871,90369,98767,76666,78063,43262,952
Gross Profit
14,25115,10815,05012,97313,17413,10613,87612,14412,00812,98912,10713,60813,30013,32913,04113,53613,19213,71013,22613,285
Selling, General & Admin
11,31911,03610,93211,32110,85810,34710,58410,36410,49910,23610,13010,1709,7829,7059,5379,8019,6119,1869,3249,849
Operating Expenses
11,31911,03610,93211,32110,85810,34710,58410,36410,49910,23610,13010,1709,7829,7059,5379,8019,6119,1869,3249,849
Operating Income
2,9324,0724,1181,6522,3162,7593,2921,7801,5092,7531,9773,4383,5183,6243,5043,7353,5814,5243,9023,436
Interest Expense
-747-757-774-787-784-763-785-758-752-732-716-690-693-686-589-552-566-583-586-608
Interest & Investment Income
647641574594632487520755550394454268277274334323201146168367
Other Non Operating Income (Expenses)
303132-88262928-79252425-72222222-128404242-147
EBT Excluding Unusual Items
2,8623,9873,9501,3712,1902,5123,0551,6981,3322,4391,7402,9443,1243,2343,2713,3783,2564,1293,5263,048
Merger & Restructuring Charges
-13-10-12-17-110-32-51-63-1,227-102-60-239-105-664-43-117----1,389
Impairment of Goodwill
-----5,725---------------
Gain (Loss) on Sale of Assets
----483----------349-12-2,480--41-
Legal Settlements
-----320-833-387----100-----99-5,220--484-
Other Unusual Items
-------491------------89
Pretax Income
2,8493,9773,9381,354-3,4821,6472,6172,1261052,3371,5802,7053,0192,5702,8793,150-4,4444,1293,0011,570
Income Tax Expense
678982981-1,56950863483550334569456658754656737818-1,0451,090646274
Earnings From Continuing Operations
2,1712,9952,9572,923-3,9901,0131,7821,623711,7681,1242,0472,2651,9142,1422,332-3,3993,0392,3551,296
Net Income to Company
2,1712,9952,9572,923-3,9901,0131,7821,623711,7681,1242,0472,2651,9142,1422,332-3,3993,0392,3551,296
Minority Interest in Earnings
1-16-1420158-321162-11-1-4-13-62-7-10-110
Net Income
2,1722,9792,9432,943-3,9751,0211,7791,644871,7701,1132,0462,2611,9012,1362,334-3,4063,0292,3541,306
Net Income to Common
2,1722,9792,9432,943-3,9751,0211,7791,644871,7701,1132,0462,2611,9012,1362,334-3,4063,0292,3541,306
Net Income Growth (YoY)
-191.77%65.43%79.02%--42.32%59.84%-19.65%-96.15%-6.89%-47.89%-12.34%--37.24%-9.26%78.71%-8.84%5.89%-
Shares Outstanding (Basic)
1,2821,2791,2731,2701,2691,2661,2611,2591,2591,2561,2601,2881,2871,2831,2831,3101,3151,3131,3121,322
Shares Outstanding (Diluted)
1,2911,2871,2791,2771,2691,2701,2641,2611,2591,2591,2671,2931,2901,2871,2911,3191,3151,3211,3281,336
Shares Change (YoY)
1.73%1.34%1.19%1.27%0.79%0.87%-0.24%-2.48%-2.40%-2.18%-1.86%-1.97%-1.90%-2.57%-2.79%-1.27%-1.05%-0.45%0.45%-
EPS (Basic)
1.692.332.312.32-3.130.811.411.310.071.410.881.591.761.481.661.78-2.592.311.790.99
EPS (Diluted)
1.682.312.302.31-3.130.801.411.310.071.410.881.591.751.481.651.77-2.592.291.770.98
EPS Growth (YoY)
-188.75%63.12%76.55%--43.23%60.23%-17.80%-96.05%-4.78%-46.67%-10.47%--35.37%-6.78%81.77%-9.05%5.36%-

Additional Metrics

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Free Cash Flow
3,9075,6543,4002,606981,2903,8131,092-1,4152,4514,198-3,5472,1715,3176,454-2,6408,5435,0352,5123,408
Free Cash Flow Per Share
3.034.392.662.040.081.023.020.87-1.121.953.31-2.741.684.135.00-2.006.503.811.892.55
Dividend Per Share
0.6650.6650.6650.6650.6650.6650.6650.6650.6650.6650.6650.6050.6050.6050.6050.5500.5500.5500.5500.500
Dividend Growth (YoY)
0%0%0%0%0%0%0%9.92%9.92%9.92%9.92%10.00%10.00%10.00%10.00%10.00%10.00%10.00%10.00%-
Gross Margin
13.23%14.33%15.07%12.34%12.88%13.31%14.75%12.53%12.66%14.30%13.76%14.55%14.86%15.04%15.35%16.21%16.30%17.03%17.25%17.43%
Operating Margin
2.72%3.86%4.12%1.57%2.27%2.80%3.50%1.84%1.59%3.03%2.25%3.67%3.93%4.09%4.13%4.47%4.42%5.62%5.09%4.51%
Profit Margin
2.02%2.83%2.95%2.80%-3.89%1.04%1.89%1.70%0.09%1.95%1.26%2.19%2.53%2.14%2.51%2.79%-4.21%3.76%3.07%1.71%
Free Cash Flow Margin
3.63%5.36%3.40%2.48%0.10%1.31%4.05%1.13%-1.49%2.70%4.77%-3.79%2.43%6.00%7.60%-3.16%10.55%6.25%3.28%4.47%
EBITDA
4,0645,1985,2332,7993,4503,9304,4462,9272,6703,9043,1154,5724,6454,7284,5054,7784,6315,6064,9514,551
EBITDA Margin
3.77%4.93%5.24%2.66%3.37%3.99%4.73%3.02%2.81%4.30%3.54%4.89%5.19%5.33%5.30%5.72%5.72%6.97%6.46%5.97%
D&A For EBITDA
1,1321,1261,1151,1471,1341,1711,1541,1471,1611,1511,1381,1341,1271,1041,0011,0431,0501,0821,0491,115
EBIT
2,9324,0724,1181,6522,3162,7593,2921,7801,5092,7531,9773,4383,5183,6243,5043,7353,5814,5243,9023,436
EBIT Margin
2.72%3.86%4.12%1.57%2.27%2.80%3.50%1.84%1.59%3.03%2.25%3.67%3.93%4.09%4.13%4.47%4.42%5.62%5.09%4.51%
Effective Tax Rate
23.80%24.69%24.91%--38.49%31.91%23.66%32.38%24.35%28.86%24.32%24.98%25.52%25.60%25.97%-26.40%21.53%17.45%
Revenue as Reported
108,399106,096100,426105,693102,87198,91594,58897,71095,42891,23488,43793,81389,76488,92185,27883,84681,15980,63676,82676,604
SEC Filings: 10-K · 10-Q